ResearcherNecmettin Erbakan UniversityNo recent work listed

Ebru Avcı

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5110259579. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

The effects of Juglone-Selenium combination on invasion and metastasis in pancreatic cancer cell lines. Last author DOI 10.4314/ahs.v22i2.37 ↗
Investigation of juglone effects on metastasis and angiogenesis in pancreatic cancer cells. Co-author DOI 10.1016/j.gene.2016.05.001 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hilal Arıkoğlu · 2 shared papers, 2016–2022 · strength 0.32
- Paper The effects of Juglone-Selenium combination on invasion and metastasis in pancreatic cancer cell lines. DOI 10.4314/ahs.v22i2.37 ↗
- Paper Investigation of juglone effects on metastasis and angiogenesis in pancreatic cancer cells. DOI 10.1016/j.gene.2016.05.001 ↗
Dudu Erkoç Kaya · 2 shared papers, 2016–2022 · strength 0.32
- Paper The effects of Juglone-Selenium combination on invasion and metastasis in pancreatic cancer cell lines. DOI 10.4314/ahs.v22i2.37 ↗
- Paper Investigation of juglone effects on metastasis and angiogenesis in pancreatic cancer cells. DOI 10.1016/j.gene.2016.05.001 ↗
Duygu Dursunoğlu · 1 shared paper, 2022 · strength 0.22
- Paper The effects of Juglone-Selenium combination on invasion and metastasis in pancreatic cancer cell lines. DOI 10.4314/ahs.v22i2.37 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.